Norway Savings Bank Biogen Inc. Transaction History

Norway Savings Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	BUY	$194.69 - $268.46 $7,787 - $10,738	40 Added 200.0%	60 $16,000
Q2 2020 Jul 07, 2020	BUY	$258.66 - $342.55 $5,173 - $6,851	20 New	20 $5,000
Q1 2019 Apr 12, 2019	SELL	$216.71 - $338.96 $182,903 - $286,082	-844 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$278.5 - $352.75 $3,342 - $4,233	-12 Reduced 1.4%	844 $254,000
Q3 2018 Oct 16, 2018	SELL	$293.51 - $383.83 $63,104 - $82,523	-215 Reduced 20.07%	856 $302,000
Q2 2018 Jul 12, 2018	SELL	$257.52 - $306.91 $8,498 - $10,128	-33 Reduced 2.99%	1,071 $311,000
Q1 2018 Apr 10, 2018	SELL	$260.13 - $367.91 $9,624 - $13,612	-37 Reduced 3.24%	1,104 $302,000
Q4 2017 Jan 16, 2018	SELL	$307.64 - $344.58 $3,076 - $3,445	-10 Reduced 0.87%	1,141 $363,000
Q3 2017 Oct 20, 2017	BUY	$281.15 - $329.69 $323,603 - $379,473	1,151	1,151 $360,000

990

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Norway Savings Bank, based on Form 13F filings with the SEC.

Stay updated on Norway Savings Bank with notifications on news.